{"name":"Laurus Labs","slug":"laurus-labs","ticker":"LAURUSLABS.NS","exchange":"NSE","domain":"lauruslabs.com","description":"Laurus Labs Limited, together with its subsidiaries, manufactures and sells medicines and active pharmaceutical ingredients (APIs) in India and internationally. The company offers Generics APIs and oral solid formulations for advanced intermediates for anti-retroviral (ARV), antidiabetic, cardiovascular, anti-asthma, ophthalmology, oncology, gastroenterology, and hepatitis C therapeutic areas. It also provides biotechnology services used in the nutraceutical, dietary supplements, alternate food proteins, and cosmeceutical products. In addition, the company develops novel enzymatic solutions for industrial biotechnology, and animal origin free recombinant proteins and enzymes for biopharma; and offers business support services for pharmaceuticals field. Laurus Labs Limited was incorporated in 2005 and is based in Hyderabad, India.","hq":"Hyderabad, India","founded":0,"employees":"","ceo":"","sector":"API / CDMO / Anti-Retrovirals / Oncology","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":1315.5,"stockChange":35,"stockChangePercent":2.73,"marketCap":"$7.4B","metrics":{"revenue":717194057.8348565,"revenueGrowth":6,"grossMargin":60.8,"rdSpend":0,"netIncome":92814332.70544384,"cash":11873433.369662464,"dividendYield":19,"peRatio":84.2,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"yahoo_finance","revenue":575173372.0364,"revenuePeriod":"2025-03-31","revenueHistory":[{"period":"2025-03-31","value":575173372.0364},{"period":"2024-03-31","value":522326669.932},{"period":"2023-03-31","value":628051402.4628},{"period":"2022-03-31","value":510499184.0996}],"grossProfit":309988524.80300003,"grossProfitHistory":[{"period":"2025-03-31","value":309988524.80300003},{"period":"2024-03-31","value":261352349.17540002},{"period":"2023-03-31","value":331402477.1674},{"period":"2022-03-31","value":275712207.7028}],"rdSpend":5774854.022,"rdSpendHistory":[{"period":"2025-03-31","value":5774854.022},{"period":"2024-03-31","value":4569757.9024},{"period":"2023-03-31","value":2672305.8666},{"period":"2022-03-31","value":3077485.4978}],"sgaSpend":26244779.6168,"operatingIncome":65286134.493200004,"operatingIncomeHistory":[{"period":"2025-03-31","value":65286134.493200004},{"period":"2024-03-31","value":41235381.6938},{"period":"2023-03-31","value":135157691.0498},{"period":"2022-03-31","value":122455100.7562}],"netIncome":37418547.7968,"netIncomeHistory":[{"period":"2025-03-31","value":37418547.7968},{"period":"2024-03-31","value":16765873.657},{"period":"2023-03-31","value":82509401.6514},{"period":"2022-03-31","value":86416043.4048}],"eps":6.64,"epsHistory":[{"period":"2025-03-31","value":6.64},{"period":"2024-03-31","value":2.97},{"period":"2023-03-31","value":14.64},{"period":"2022-03-31","value":15.35}],"cash":10394737.2396,"cashHistory":[{"period":"2025-03-31","value":10394737.2396},{"period":"2024-03-31","value":14509190.195600001},{"period":"2023-03-31","value":4769214.8858},{"period":"2022-03-31","value":7892648.5892}],"totalAssets":974892476.7118,"totalLiabilities":494261714.807,"totalDebt":288610077.8702,"equity":467059332.8144,"operatingCashflow":62828949.771,"operatingCashflowHistory":[{"period":"2025-03-31","value":62828949.771},{"period":"2024-03-31","value":69516502.2406},{"period":"2023-03-31","value":103790730.786},{"period":"2022-03-31","value":95144113.914}],"capex":-66938181.34,"capexHistory":[{"period":"2025-03-31","value":-66938181.34},{"period":"2024-03-31","value":-70834380.3194},{"period":"2023-03-31","value":-103400171.0384},{"period":"2022-03-31","value":-91566419.5416}],"freeCashflow":-4109231.569,"dividendsPaid":-4503968.4262,"buybacks":null,"employees":0,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[{"sga":null,"ebit":38152674.809,"ebitda":50748748.8078,"period":"2025-12-31","revenue":185702805.7646,"epsBasic":4.67,"netIncome":26280285.0484,"rdExpense":null,"epsDiluted":4.65,"grossProfit":113170430.3928,"operatingIncome":37551171.0266},{"sga":null,"ebit":28792816.4728,"ebitda":40994153.6144,"period":"2025-06-30","revenue":163906647.8718,"epsBasic":3.02,"netIncome":17023810.1748,"rdExpense":null,"epsDiluted":3.02,"grossProfit":97349627.7828,"operatingIncome":27703635.1446},{"sga":null,"ebit":37524019.8142,"ebitda":49057019.4198,"period":"2025-03-31","revenue":174832922.308,"epsBasic":null,"netIncome":24401630.0058,"rdExpense":null,"epsDiluted":null,"grossProfit":86684422.6966,"operatingIncome":32389307.8384},{"sga":null,"ebit":19682540.435200002,"ebitda":30761279.3718,"period":"2024-12-31","revenue":147770473.487,"epsBasic":1.71,"netIncome":9638680.402,"rdExpense":null,"epsDiluted":1.71,"grossProfit":84053887.926,"operatingIncome":18698831.1244},{"sga":null,"ebit":7875940.1508,"ebitda":19102966.4782,"period":"2024-09-30","revenue":127788225.43800001,"epsBasic":0.37,"netIncome":2071846.3616,"rdExpense":null,"epsDiluted":0.37,"grossProfit":70530495.596,"operatingIncome":7395572.5468}]},"ciks":null,"lastFiledAt":null},"yahoo":{"currentPrice":1315.5,"previousClose":1280.5,"fiftyTwoWeekHigh":1324.1,"fiftyTwoWeekLow":584.5,"fiftyTwoWeekRange":"584.5 - 1324.1","fiftyDayAverage":1079.74,"twoHundredDayAverage":996.34,"beta":0,"enterpriseValue":7682007573.292122,"forwardPE":54.8,"priceToBook":14.79,"priceToSales":10.34,"enterpriseToRevenue":10.71,"enterpriseToEbitda":40.14,"pegRatio":0,"ebitda":191380538.64671233,"ebitdaMargin":26.7,"freeCashflow":-2360589.0627,"operatingCashflow":169538433.88498738,"totalDebt":262999182.65525043,"debtToEquity":46.4,"currentRatio":1.33,"returnOnAssets":8.5,"returnOnEquity":17.7,"analystRating":"2.9 - Hold","recommendationKey":"hold","numberOfAnalysts":14,"targetMeanPrice":1027.29,"targetHighPrice":1370,"targetLowPrice":510,"dividendRate":2.4,"payoutRatio":0.1,"fiveYearAvgDividendYield":0.32,"exDividendDate":1778198400,"insiderHeldPercent":32.1,"institutionHeldPercent":30.4,"sharesOutstanding":539856582,"floatShares":363324736,"sharesShort":0,"shortRatio":0,"shortPercentOfFloat":0,"epsTrailing":15.62,"epsForward":24.02,"revenuePerShare":127.27,"bookValue":88.97,"officers":[{"age":64,"name":"Dr. Satyanarayana  Chava M.Sc., Ph.D.","title":"CEO & Whole Time Director"},{"age":60,"name":"Mr. Vantaram Venkata Ravi Kumar Dip in Mgmt., DIS, F.C.M.A.","title":"CFO & Whole-Time Director"},{"age":57,"name":"Mr. B. V. R. K. Suryadevara Srinivasa Rao","title":"President of Manufacturing and Operations"},{"age":null,"name":"Mr. Gogireddy Venkateswar Reddy","title":"VP of Legal, Compliance Officer & Company Secretary"},{"age":57,"name":"Mr. Narasimha Rao Chava","title":"Executive Vice President of Human Resources"},{"age":63,"name":"Dr. Lakshmana Rao Venkata Chunduru M.Sc., Ph.D.","title":"Executive Director of Quality & Executive Director"},{"age":62,"name":"Mr. Srinivasa Rao Suryadevara B.Sc, M.Sc.","title":"Executive Vice President of Manufacturing"},{"age":52,"name":"Mr. Chagarlamudi Sita Ramaiah","title":"Executive Vice President of Finance"}],"industry":"Drug Manufacturers - Specialty & Generic","irWebsite":"","website":"https://www.lauruslabs.com","phone":"91 40 3980 4333"}}